June 24, 2020 / 11:28 AM / 15 days ago

BRIEF-Fulcrum Announces Initiation Of Multi-Center Phase 3 Trial With Losmapimod For Covid-19 Patients

June 24 (Reuters) - Fulcrum Therapeutics Inc:

* FULCRUM THERAPEUTICS ANNOUNCES INITIATION OF MULTI-CENTER PHASE 3 (LOSVID) TRIAL WITH LOSMAPIMOD FOR HOSPITALIZED COVID-19 PATIENTS

* FULCRUM THERAPEUTICS INC - TOPLINE DATA IS EXPECTED TO BE REPORTED IN Q1 OF 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below